Ardelyx (ARDX) Debt Ratio (2018 - 2026)
Ardelyx (ARDX) reported Debt Ratio of 0.4 for Q1 2026, up 9.37% on a YoY basis from 0.37 in Q1 2025, and little changed quarter-over-quarter from 0.4 in Q4 2025.
Ardelyx (ARDX) Debt Ratio (2018 - 2026) Analysis & Trends
Ardelyx has reported Debt Ratio for 9 years, with the latest figure at 0.4 in Q1 2026.
- For the quarter ending Q1 2026, Debt Ratio rose 9.37% year-over-year to 0.4; the trailing twelve-month figure through Mar 2026 stood at 0.4 (up 9.37% YoY), and the FY2025 full-year result was 0.4, up 16.81% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.4, roughly flat from 0.4 in the prior quarter.
- The five-year high for Debt Ratio was 0.43 in Q2 2025, with the low at 0.09 in Q3 2023.
- Historically, Debt Ratio has averaged 0.26 across 5 years, with a median of 0.27 in 2024.
- Annual changes were most pronounced in 2023 — Debt Ratio tumbled 48.71% — and 2024, when it soared 190.94%.
- Ardelyx's Debt Ratio stood at 0.14 in 2022, then increased by 19.13% to 0.17 in 2023, then jumped by 106.77% to 0.35 in 2024, then gained by 16.81% to 0.4 in 2025, then decreased by 0.24% to 0.4 in 2026.
- The last three Debt Ratio figures came in at 0.4 (Q1 2026), 0.4 (Q4 2025), and 0.42 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.18 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | 0.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.40 |
| Dec 31, 2025 | 0.40 |
| Sep 30, 2025 | 0.42 |
| Jun 30, 2025 | 0.43 |
| Mar 31, 2025 | 0.37 |
| Dec 31, 2024 | 0.35 |
| Sep 30, 2024 | 0.27 |
| Jun 30, 2024 | 0.29 |
| Mar 31, 2024 | 0.29 |
| Dec 31, 2023 | 0.17 |
| Sep 30, 2023 | 0.09 |
| Jun 30, 2023 | 0.13 |
| Mar 31, 2023 | 0.12 |
| Dec 31, 2022 | 0.14 |
| Sep 30, 2022 | 0.18 |
| Jun 30, 2022 | 0.20 |
| Mar 31, 2022 | 0.20 |
| Dec 31, 2021 | 0.22 |
| Sep 30, 2021 | 0.30 |
| Jun 30, 2021 | 0.25 |